Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Foxx Life Sciences Announces Opening of New Asia Headquarters in India 2020-11-17 21:00
Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments 2020-11-17 20:00
Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety 2020-11-17 18:49
Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of Camcevi(TM) in China 2020-11-17 17:51
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event 2020-11-17 16:29
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event 2020-11-17 15:00
QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours 2020-11-17 11:51
Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus 2020-11-17 09:00
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-17 01:09
Covis Group Completes Acquisition of AMAG Pharmaceuticals 2020-11-16 22:43
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-16 21:42
Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores 2020-11-16 21:00
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020 2020-11-16 21:00
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society 2020-11-16 20:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense 2020-11-16 20:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology 2020-11-16 08:00
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results 2020-11-14 05:10
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) 2020-11-14 01:03
1 272 273 274 275 276 412